Homelife sciences

life sciences

Nabriva Therapeutics Announces Proposed Public Offering

Nabriva Therapeutics Announces Proposed Public Offering

December 10, 2020

Ampio Enters into Collaborative Research Agreements to Explore Additional Clinical Indications for its Immunomodulatory Drug, Ampion

Ampio Enters into Collaborative Research Agreements to Explore Additional Clinical Indications for its Immunomodulatory Drug, Ampion

December 10, 2020

Trevena, Inc. Announces Presentations Highlighting Novel S1P1 Receptor Modulator at the American College of Neuropsychopharmacology 59th Annual Meeting

Trevena, Inc. Announces Presentations Highlighting Novel S1P1 Receptor Modulator at the American College of Neuropsychopharmacology 59th Annual Meeting

December 10, 2020

Entera Bio Announces FDA Approval of IND Application for EB613 – an Oral Human Parathyroid Hormone (1-34) for the Treatment of Osteoporosis

Entera Bio Announces FDA Approval of IND Application for EB613 – an Oral Human Parathyroid Hormone (1-34) for the Treatment of Osteoporosis

December 10, 2020

Heat Biologics Provides Business Update

Heat Biologics Provides Business Update

December 10, 2020

Arbutus Announces Robust HBsAg Decline Data with AB-729 Dosed at 60 mg Every 8 Weeks in Chronic Hepatitis B Subjects

Arbutus Announces Robust HBsAg Decline Data with AB-729 Dosed at 60 mg Every 8 Weeks in Chronic Hepatitis B Subjects

December 10, 2020

Actinium Pharmaceuticals (ATNM) Gains As Market Dips: What You Should Know

Actinium Pharmaceuticals (ATNM) Gains As Market Dips: What You Should Know

December 9, 2020

ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders

ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders

December 9, 2020

Citius Pharmaceuticals Receives FDA Response and Guidance to Pre-IND Consultation Submission for Mino-Wrap

Citius Pharmaceuticals Receives FDA Response and Guidance to Pre-IND Consultation Submission for Mino-Wrap

December 9, 2020

Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer

Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer

December 9, 2020

« 1 … 550 551 552 553 554 … 557 »